NorthRock Partners LLC Has $489,000 Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

NorthRock Partners LLC grew its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 127.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,253 shares of the company's stock after acquiring an additional 3,498 shares during the quarter. NorthRock Partners LLC's holdings in GE HealthCare Technologies were worth $489,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. JPMorgan Chase & Co. grew its holdings in shares of GE HealthCare Technologies by 29.8% during the third quarter. JPMorgan Chase & Co. now owns 2,233,603 shares of the company's stock worth $209,624,000 after purchasing an additional 512,778 shares during the last quarter. Miracle Mile Advisors LLC bought a new stake in shares of GE HealthCare Technologies during the fourth quarter worth about $240,000. Park Avenue Securities LLC grew its holdings in shares of GE HealthCare Technologies by 9.7% during the fourth quarter. Park Avenue Securities LLC now owns 4,450 shares of the company's stock worth $348,000 after purchasing an additional 392 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. grew its holdings in shares of GE HealthCare Technologies by 26.0% during the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,304 shares of the company's stock worth $102,000 after purchasing an additional 269 shares during the last quarter. Finally, Pinnacle Bancorp Inc. grew its holdings in shares of GE HealthCare Technologies by 107.8% during the fourth quarter. Pinnacle Bancorp Inc. now owns 771 shares of the company's stock worth $60,000 after purchasing an additional 400 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company's stock.

Analysts Set New Price Targets

Several analysts have recently weighed in on the company. BTIG Research set a $95.00 price target on GE HealthCare Technologies and gave the stock a "buy" rating in a report on Monday, April 14th. The Goldman Sachs Group reduced their price target on GE HealthCare Technologies from $94.00 to $82.00 and set a "buy" rating on the stock in a report on Thursday, May 1st. Morgan Stanley reduced their price target on GE HealthCare Technologies from $86.00 to $78.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. UBS Group upgraded GE HealthCare Technologies from a "sell" rating to a "neutral" rating and reduced their target price for the company from $74.00 to $73.00 in a report on Monday, May 5th. Finally, Piper Sandler reduced their target price on GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating on the stock in a report on Wednesday, April 23rd. Three equities research analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $88.27.

GE HealthCare Technologies Trading Down 1.7%

Shares of GE HealthCare Technologies stock traded down $1.25 on Tuesday, reaching $71.85. 3,268,213 shares of the company's stock were exchanged, compared to its average volume of 3,414,232. The company has a market capitalization of $32.90 billion, a P/E ratio of 16.59, a price-to-earnings-growth ratio of 3.19 and a beta of 1.21. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80. The firm's 50-day moving average is $71.06 and its two-hundred day moving average is $80.02. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings results on Wednesday, April 30th. The company reported $1.01 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.91 by $0.10. The firm had revenue of $4.78 billion for the quarter, compared to analysts' expectations of $4.66 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company's revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.90 EPS. Sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, May 15th. Shareholders of record on Friday, April 25th were issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.19%. The ex-dividend date of this dividend was Friday, April 25th. GE HealthCare Technologies's payout ratio is 2.95%.

GE HealthCare Technologies declared that its board has initiated a share repurchase program on Wednesday, April 30th that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the company to repurchase up to 3.1% of its stock through open market purchases. Stock buyback programs are generally a sign that the company's board believes its shares are undervalued.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.